Longeveron Inc (LGVN)

Dec 18, 2024

Longeveron to Present at Biotech Showcase 2025 - The Manila Times

Dec 18, 2024

Dec 18, 2024

Longeveron CEO to Present at Biotech Showcase 2025: Spotlight on Regenerative Medicine Breakthroughs - StockTitan

Dec 18, 2024

Dec 08, 2024

Longeveron (NASDAQ:LGVN) Upgraded at Roth Capital - Defense World

Dec 08, 2024

Dec 07, 2024

Longeveron initiated with a Buy at Roth MKM - Yahoo Finance

Dec 07, 2024

Dec 06, 2024

Roth MKM Initiates Coverage of Longeveron (LGVN) with Buy Recommendation - MSN

Dec 06, 2024

Dec 04, 2024

Longeveron director Baluch Khoso sells $2,588 in stock By Investing.com - Investing.com Canada

Dec 04, 2024

Dec 04, 2024

Longeveron director Baluch Khoso sells $2,588 in stock - Investing.com

Dec 04, 2024

Dec 02, 2024

Longeveron to Present at the Emerging Growth Virtual Conference on December 5, 2024 - Marketscreener.com

Dec 02, 2024

Nov 28, 2024

Longeveron FY2024 EPS Forecast Increased by HC Wainwright - Defense World

Nov 28, 2024

Nov 27, 2024

Longeveron (NASDAQ:LGVN) Earns “Buy” Rating from HC Wainwright - Defense World

Nov 27, 2024

Nov 25, 2024

H.C. Wainwright reiterates Buy on Longeveron stock, raises target by 25% on trial progress - Investing.com India

Nov 25, 2024

Nov 23, 2024

Longeveron Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 23, 2024

Nov 20, 2024

Longeveron stock opened 100% up on Wednesday: explore why - MSN

Nov 20, 2024

Nov 15, 2024

We're Keeping An Eye On Longeveron's (NASDAQ:LGVN) Cash Burn Rate - Yahoo Finance

Nov 15, 2024

Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires New Stake in Longeveron Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

The Escalator: Sanofi, Longeveron, Geron and more - MM+M Online

Nov 14, 2024

Nov 13, 2024

Earnings call: Longeveron Q3 2024 results show promise in regenerative medicine - Investing.com

Nov 13, 2024

Nov 13, 2024

Longeveron Inc. (NASDAQ:LGVN) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 13, 2024

Nov 12, 2024

Longeveron reports Q3 EPS (34c), consensus (44c) - TipRanks

Nov 12, 2024

Nov 12, 2024

Longeveron® Announces Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

LGVNLongeveron Inc. Latest Stock News & Market Updates - StockTitan

Nov 12, 2024

Nov 11, 2024

A Look Ahead: Longeveron's Earnings Forecast - Benzinga

Nov 11, 2024

Nov 11, 2024

Longeveron names Devin Blass as new CTO - Investing.com

Nov 11, 2024

Nov 11, 2024

Longeveron names Devin Blass as new CTO By Investing.com - Investing.com UK

Nov 11, 2024

Nov 11, 2024

Longeveron Taps Devin Blass As CTO And SVP Of CMC - Contract Pharma

Nov 11, 2024

Nov 11, 2024

Longeveron Taps Devin Blass As CTO And SVP Of Chemistry, Manufacturing And Controls - Contract Pharma

Nov 11, 2024

Nov 11, 2024

Longeveron® Appoints Devin Blass as Chief Technology Officer and SVP of Chemistry, Manufacturing and Controls (CMC) - The Manila Times

Nov 11, 2024

Nov 11, 2024

Longeveron Strengthens Leadership: Key Executive Hire Ahead of Critical BLA Submission | LGVN Stock News - StockTitan

Nov 11, 2024

Nov 11, 2024

Earnings To Watch: Longeveron Inc (LGVN) Reports Q3 2024 Result - Yahoo Finance

Nov 11, 2024

Nov 05, 2024

Longeveron® to Report Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024 - StockTitan

Nov 05, 2024

Nov 04, 2024

Peeling Back The Layers: Exploring Longeveron Through Analyst Insights - Benzinga

Nov 04, 2024

Oct 30, 2024

Longeveron presents Alzheimer's therapy data at CTAD24 - Investing.com

Oct 30, 2024

Oct 29, 2024

Longeveron® Presents Lomecel-B™ Data for Alzheimer's Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - The Manila Times

Oct 29, 2024

Oct 29, 2024

Longeveron presents Alzheimer's therapy data at CTAD24 By Investing.com - Investing.com UK

Oct 29, 2024

Oct 29, 2024

Longeveron® Presents Lomecel-B™ Data for Alzheimer’s Disease Indication in Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) - StockTitan

Oct 29, 2024

Oct 27, 2024

Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - ForexTV.com

Oct 27, 2024

Oct 27, 2024

Longeveron® Presents Lomecel-B™ Long-term Transplant-free Survival Data in Hypoplastic Left Heart Syndrome (HLHS) at the Congenital Heart Surgeons’ Society (CHSS) 51st Annual Meeting - GlobeNewswire Inc.

Oct 27, 2024

Oct 27, 2024

TSX Venture Composite Index (JX) QuotePress Release - The Globe and Mail

Oct 27, 2024

Oct 25, 2024

Why has Longeveron stock tripled in two days? - MSN

Oct 25, 2024

Oct 24, 2024

Euro FX (E6N18) Quote - The Globe and Mail

Oct 24, 2024

Oct 23, 2024

S&P 500 Index (INX) QuotePress Release - The Globe and Mail

Oct 23, 2024

Oct 23, 2024

Scholastic Corp (SCHL-Q) QuotePress Release - The Globe and Mail

Oct 23, 2024

Oct 15, 2024

LGVN’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

Oct 15, 2024

Oct 14, 2024

LGVNRLongeveron Inc. Latest Stock News & Market Updates - StockTitan

Oct 14, 2024

Oct 14, 2024

Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) - ForexTV.com

Oct 14, 2024

Oct 14, 2024

Longeveron® Lomecel-B™ Data in Alzheimer's Disease Selected for Late Breaking Poster Presentation at the Clinical Trials on Alzheimer's Disease Conference (CTAD24) - The Manila Times

Oct 14, 2024

Oct 14, 2024

Longeveron® Lomecel-B™ Data in Alzheimer’s Disease Selected - GlobeNewswire

Oct 14, 2024